pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
MAb AR9.6
Pancreatic Cancer
OncoCare Therapeutics Inc
0
catalysts
Phase 1
MB-101
Brain Tumor
$MBIO
MUSTANG BIO, INC.
0
catalysts
Phase 2
MB-105
Cutaneous T-Cell Lymphoma
March Biosciences
0
catalysts
Phase 1
MB-108
← prev
page 106 of 231
next →
131
Pain
89
Neurology
1
Anaplastic Astrocytoma
$MBIO
MUSTANG BIO, INC.
0
catalysts
Preclinical
MB-204
Alzheimer's Disease
Marvel Biotechnology Inc
0
catalysts
Preclinical
MBP-091
Marburgvirus Infections (Marburg Hemorrhagic Fever)
Mapp Biopharmaceutical Inc
0
catalysts
Phase 1
MBP-134
Ebolavirus Infections (Ebola Hemorrhagic Fever)
Mapp Biopharmaceutical Inc
0
catalysts
Phase 1
MBQ-167
Triple-Negative Breast Cancer (TNBC)
MBQ Pharma Inc
0
catalysts
Phase 1
MBX-4291
Obesity
$MBX
MBX Biosciences, Inc.
0
catalysts
Phase 2
MC-001
Spinal Cord Injury
StemCyte Inc
0
catalysts
Phase 3
MC-1
heart failure
$MCUJF
MEDICURE INC
0
catalysts
Preclinical
MC-16
Retinitis Pigmentosa (Retinitis)
Mitochem Therapeutics, LLC
0
catalysts
Phase 2
MC-232
Hidradenitis Suppurativa
MC2 Therapeutics AS
0
catalysts
Phase 1
MCLA-145
Solid Tumor
Merus NV
0
catalysts
Phase 1
MCM-998
Multiple Myeloma (Kahler Disease)
$NVS
NOVARTIS AG
0
catalysts
Preclinical
MCR-231
Neurotrophic Keratitis
MicroCures Inc
0
catalysts
Preclinical
MDC-WWM
Female Contraception
MedinCell SA
0
catalysts
Phase 2
MDI-1228
Diabetic Foot Ulcers
Henan Maiyingnuo Pharmaceutical Technology Co Ltd
0
catalysts
Preclinical
MDL-101
Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Mu…
Modalis Therapeutics Corp
0
catalysts
Preclinical
MDL-204
Unspecified Central Nervous System Disorders
Modalis Therapeutics Corp
0
catalysts
Preclinical
MDMA Patch
Unspecified Psychiatric Disorders
PharmaTher Holdings Ltd
0
catalysts
Phase 2
MDNA-11
Solid Tumor
$MDNAF
Medicenna Therapeutics Corp.
0
catalysts
Phase 2
MDX-1097
Refractory Multiple Myeloma
HaemaLogix Pty Ltd
0
catalysts
Phase 1
MDX-2301
Coronavirus Disease 2019 (COVID-19)
ModeX Therapeutics Inc
0
catalysts
Preclinical
ME-101
Neonatal Respiratory Distress Syndrome
Molecular Express Inc
0
catalysts
Phase 1
MEB-1170
Pain
Mebias Discovery LLC
0
catalysts
Phase 2
MEDI-0457
Oropharyngeal Cancer
$AZN
ASTRAZENECA PLC
0
catalysts
MEGATOPE
MEGATOPE (IODINATED I-131 ALBUMIN)
ISO TEX
0
catalysts
Phase 1
MEI-004
Alopecia
Nanjing Mainowei Pharmaceutical Technology Co Ltd.
0
catalysts
Phase 1
MEM-288
Cutaneous Squamous Cell Carcinoma (cSCC)
Memgen Inc
0
catalysts
